371 results on '"Glover, Sarah C."'
Search Results
2. Regulation of Paneth cell-specific genes in COVID-19 patients and SARS-CoV-2-infected mice by quantification of mRNA from exfoliated cells in stool samples
3. Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
4. Mast cell activation syndrome: Current understanding and research needs
5. A focused retrospective study on differences in IBD characteristics between Black and White patients in the south
6. Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms
7. Activity of Various Cathepsin Proteases and Enrichment of Klotho Protein in the Urine and Urinary Extracellular Vesicles After SARS-CoV-2 Infection.
8. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis
9. Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study
10. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond
11. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
12. Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia
13. An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection
14. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
15. Pediatric Gastrointestinal Histopathology in Patients With Tetratricopeptide Repeat Domain 7A (TTC7A) Germline Mutations: A Rare Condition Leading to Multiple Intestinal Atresias, Severe Combined Immunodeficiency, and Congenital Enteropathy
16. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn’s Disease
17. Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease
18. S2584 The Gastrointestinal Implications of a Rare Lysosomal Storage Disorder, Cystinosis
19. Enhanced production of eicosanoids in plasma and activation of DNA damage pathways in PBMCs are correlated with the severity of ancestral COVID-19 infection
20. MyD88 regulates a prolonged adaptation response to environmental dust exposure-induced lung disease
21. Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn’s Disease
22. Innate Lymphoid Cells in Inflammatory Bowel Disease
23. Immune marker reductions in black and white Americans following sleeve gastrectomy in the short-term phase of surgical weight loss
24. Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency
25. Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
26. Black Inflammatory Bowel Disease Patients Have Lower Response to Antitumor Necrosis Factor Agents Compared With White Patients.
27. SARS-CoV2 Decreases Human Beta-Defensin-1 and FoxI1 in the Oral Cavity Without Affecting CFTR
28. COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells
29. Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing
30. Severe COVID-19 is associated with fungal colonization of the nasopharynx and potent induction of IL-17 responses in the nasal epithelium
31. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD
32. The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients
33. Getting by With Less: How to do More With Less Staff After COVID-19?
34. Genetically determining individualized clinical reference ranges for the biomarker tryptase can limit unnecessary procedures and unmask myeloid neoplasms
35. Meta-genomic detection of Candida spp. in the nasopharynx and upper airway of patients with severe COVID-19
36. Human Defensin-5 (HD-5) and HD-6 mRNA Produced by Intestinal Crypt Paneth Cells are Decreased in Fecal Samples of Patients Positive for SARS-CoV2
37. Circulating extracellular vesicles from patients with severe COVID-19 upregulate Cathepsin B and activate STAT3 in normal human mesangial cells
38. Increased tryptase expression in HαT is associated with upregulation of epithelia-derived MRGPRX2 agonists and MRGPRX2+ MCs in the GI mucosa
39. 653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION
40. 656: POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
41. Hereditary alpha-tryptasemia despite normal tryptase-encoding gene copy number owing to copy number loss in trans
42. Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study
43. Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients.
44. S890 Racial Differences in Musculoskeletal Comorbidities in Inflammatory Bowel Disease Patients
45. S717 Lower Therapeutic Response to Anti-TNF Agents in African Americans with Inflammatory Bowel Disease
46. S896 Clinical Manifestations of Crohn’s Disease in African Americans in a Rural versus Urban Setting
47. S3323 Clinical Presentation of African Americans With Ulcerative Colitis in Rural vs Urban Settings
48. S762 Prevalence of Urolithiasis Is Similar in Crohn’s Disease and Ulcerative Colitis Patients
49. Response to Cheng et al.
50. The Impact of Transition Readiness and Stress on Patient-Centered Outcomes in Young Adults With Inflammatory Bowel Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.